Información:
Error:
ID
12738
Descripción
Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT02185781
Link
https://clinicaltrials.gov/show/NCT02185781
Palabras clave
Versiones (1)
- 17/12/15 17/12/15 -
Subido en
17 de diciembre de 2015
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Acute Lymphoblastic Leukemia NCT02185781
Eligibility Acute Lymphoblastic Leukemia NCT02185781
- StudyEvent: Eligibility
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT02185781
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ph+ all
Item
adult subjects with ph+ all in chr (1st or 2nd) with mrd positivity confirmed at baseline, older or equal to 60 years or not eligible for other post-chr treatment modalities.
boolean
C1960397 (UMLS CUI [1])
who score 0-1
Item
who score 0-1.
boolean
C1298651 (UMLS CUI [1])
hematopoietic, liver and renal normal functions
Item
hematopoietic, liver and renal normal functions defined as follows:wbc bigger or equal to 2.000/mm3 lymphocytes bigger or equal to 500/mm3 neutrophils bigger or equal to 1.000/mm3 platelets bigger or equal to 50.000/mm3 hb bigger or equal to 9 g/dl creatinine fewer or equal to 1.5 x uln bilirubin fewer or equal to 1.5 x uln ast and alt less than 3 times the upper limit of normal. ldh less than 2 times the upper limit of normal.
boolean
C1620290 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
effective contraception
Item
for male and female subjects of childbearing potential, agreement to use effective contraception.
boolean
C0700589 (UMLS CUI [1])
authorization
Item
authorization by istituto superiore di sanità (iss) according to dm 2 march 2004.
boolean
C0680281 (UMLS CUI [1,1])
C0018724 (UMLS CUI [1,2])
C0018724 (UMLS CUI [1,2])
informed consent
Item
signed written informed consent according to ich/eu/gcp and national local regulations.
boolean
C0021430 (UMLS CUI [1])
concomitant therapy
Item
concurrent chemotherapy or immunotherapy (tki maintenance is permitted).
boolean
C1707479 (UMLS CUI [1])
contraindication
Item
any contraindications to perform a leukapheretic procedure for mononuclear cell collection.
boolean
C1301624 (UMLS CUI [1])
infection
Item
active or chronic infection, including treponema, hiv, hbv and/or hcv unless antigen/pcr negative.
boolean
C0009450 (UMLS CUI [1])
autoimmune symptoms
Item
presence of autoimmune symptoms.
boolean
C0004364 (UMLS CUI [1])
pregnant or breastfeeding
Item
pregnant or lactating females.
boolean
C0549206 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Study subject participation status
Item
simultaneous participation in another clinical trial.
boolean
C2348568 (UMLS CUI [1])
any physical or psychological impediment in a patient that could lead the investigator to suspect his/her poor compliance to the protocol.
Item
any physical or psychological impediment in a patient that could lead the investigator to suspect his/her poor compliance to the protocol.
boolean
C1321605 (UMLS CUI [1])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])